STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) is projected to announce its earnings results before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.40) per share and revenue of $9.03 million for the quarter.
STRATA Skin Sciences Stock Performance
NASDAQ SSKN opened at $2.57 on Tuesday. The company has a quick ratio of 0.94, a current ratio of 1.13 and a debt-to-equity ratio of 1.62. The company’s 50-day simple moving average is $2.77 and its 200 day simple moving average is $2.92. The stock has a market cap of $10.72 million, a P/E ratio of -0.97 and a beta of 1.32. STRATA Skin Sciences has a twelve month low of $2.51 and a twelve month high of $5.90.
Analyst Upgrades and Downgrades
Separately, Maxim Group started coverage on STRATA Skin Sciences in a report on Thursday, February 27th. They set a “buy” rating and a $6.00 price objective for the company.
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
See Also
- Five stocks we like better than STRATA Skin Sciences
- Golden Cross Stocks: Pattern, Examples and Charts
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Upcoming IPO Stock Lockup Period, Explained
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
